Organigram Global Inc (TSX:OGI)
C$ 1.28 -0.040 (-3.03%) Market Cap: 180.19 Mil Enterprise Value: 183.29 Mil PE Ratio: 0 PB Ratio: 0.47 GF Score: 64/100

Q2 2026 Organigram Global Inc Earnings Call Transcript

May 12, 2026 / 12:00 PM GMT
Release Date Price: C$1.54 (-14.44%)

Key Points

Positve
  • Organigram Global Inc (OGI) gained 2.2 share points year-over-year in the flower segment, driven by strong performance from key cultivars and new product launches.
  • The company remains the number one licensed producer in Canada by market share in Q2, maintaining leadership positions in key markets such as Ontario, British Columbia, and Alberta.
  • Organigram Global Inc (OGI) completed the acquisition of Sanity Group, marking a significant milestone and expanding its presence in the world's two largest federally legal cannabis markets, Canada and Germany.
  • The company achieved a record quarterly harvest of over 32,000 kilograms, supported by yield improvements and advancements in genetics programs.
  • Organigram Global Inc (OGI) expects a stronger back half of the year, supported by revenue growth, margin expansion, and the financial contributions of Sanity Group.
Negative
  • Q2 was a challenging quarter with a decline in net revenue by about 9% year-over-year, primarily due to share erosion in vapes and infused pre-rolls.
  • Operational issues temporarily impacted performance in vapes and infused pre-rolls, leading to lower repurchase rates and share loss.
  • The adjusted gross margin for the quarter declined by 16% compared to the prior-year period, driven by a higher proportion of value products and higher returns.
  • The company faced challenges with out-of-spec international flower, impacting international growth and resulting in missed sales opportunities.
  • Net loss for the quarter was $0.9 million compared to net income of $42.5 million in the prior year period, primarily due to lower fair value gains and an impairment on the hemp-derived products business.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

OGI.TO - Organigram Global Inc
Q2 2026 Organigram Global Inc Earnings Call
May 12, 2026 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning. My name is Ed, and I'll be your conference operator today.

At this time, I would like to welcome everyone to the Organogram Global Second Quarter Fiscal 2026 Earnings Conference Call.

After the speaker's prepared remarks, there'll be a question-and-answer session. Please limit yourself to one question and one follow-up. You may re-queue for additional questions.

Thank you.

I'll now turn the call over to Max Schwartz, Director of Investor Relations.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you very much, and good
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot